Investigating the safety and effectiveness of platelet-rich plasma with 5% minoxidil solution in the treatment of androgenic hair loss.

A comparative study of the effect of platelet-rich plasma injection with 5% minoxidil solution versus 5% minoxidil solution in the treatment of androgenetic hair loss

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110522006543N4

Enrollment

Registered

2023-09-07

Start date

2023-09-23

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic hair loss. Androgenic alopecia, unspecified

Interventions

Intervention 1: Intervention group: Injection of platelet-rich plasma with 5% minoxidil solution for 4 weeks, 0.1 cc per centimeter for 3 months. Intervention 2: Intervention group: 5% minoxidil solut

Eligibility

Sex/Gender

Male

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Men with hereditary hormonal hair loss Age 18 years and above and less than 50 years The rate of hair loss in patients in the form of Hamilton score 2 to 5 in men Complete consent of the patient to participate in the plan

Exclusion criteria

Exclusion criteria: Having a hematological disorder Iron deficiency anemia Having coagulation disorders Bone marrow aplasia Suffering from sepsis Having cancer

Design outcomes

Primary

Measure	Time frame
Photography before and after treatment of the hair loss area. Timepoint: Before starting the intervention, each treatment session is monthly for 4 months and also 6 months after the end of the treatment. Method of measurement: Photography with a camera.;Safety. Timepoint: Before starting the intervention, each treatment session is monthly for 4 months and also 6 months after the end of the treatment. Method of measurement: Doctor's assessment of hair loss, history.;Efficacy. Timepoint: Before starting the intervention, each treatment session is monthly for 4 months and also 6 months after the end of the treatment. Method of measurement: Doctor's assessment of hair loss, patient's satisfaction, history.	—

Measure

Time frame

Photography before and after treatment of the hair loss area. Timepoint: Before starting the intervention, each treatment session is monthly for 4 months and also 6 months after the end of the treatment. Method of measurement: Photography with a camera.;Safety. Timepoint: Before starting the intervention, each treatment session is monthly for 4 months and also 6 months after the end of the treatment. Method of measurement: Doctor's assessment of hair loss, history.;Efficacy. Timepoint: Before starting the intervention, each treatment session is monthly for 4 months and also 6 months after the end of the treatment. Method of measurement: Doctor's assessment of hair loss, patient's satisfaction, history.

—

Secondary

Measure	Time frame
Side effects. Timepoint: At the beginning of the intervention, monthly for 4 months, once every month, after 6 months. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Tajbakhsh

Ahvaz University of Medical Sciences

tajbakhsh.f@ajums.ac.ir+98 903 026 8698

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026